WOONSOCKET, R.I. — The following is attributed to Karen S. Lynch, president and chief executive officer, CVS Health: “President Biden’s decision to double the number of participants in the Federal Retail Pharmacy Program is a testament to its success, and an acknowledgment that pharmacies will continue to be one of the most convenient vaccine access
WOONSOCKET, R.I. — CVS Health announced Thursday that it has nearly doubled the number of states where select CVS Pharmacy locations are offering COVID-19 vaccines to eligible populations through the Federal Retail Pharmacy Program (FRPP). The company is now administering vaccines in nearly 1,200 stores across 29 states and Puerto Rico incuding: Alabama, Arizona, California, Colorado, Connecticut,
WOONSOCKET, R.I. — CVS Health has added Alabama, Arizona, Florida, Louisiana, Ohio, and Pennsylvania to the list of states where select CVS Pharmacy locations will offer COVID-19 vaccinations to eligible populations through the Federal Retail Pharmacy Program. This follows the successful February 12 rollout in 11 states: California, Connecticut, Hawaii, Maryland, Massachusetts, New Jersey, New York, Rhode Island, South Carolina, Texas and Virginia. Appointments
WOONSOCKET, R.I. — To address housing insecurities and promote community health improvement in vulnerable populations, CVS Health invested over $114 million in affordable housing in 2020. The company’s investments over the past year will lead to the construction and rehabilitation of more than 2,800 affordable housing units in 30 cities, across 12 states. Throughout 2020,
WOONSOCKET, R.I. —CVS Health announced Friday its community-based strategy to address potential inequities related to COVID-19 vaccine access in vulnerable communities, with a particular focus on Black and Hispanic populations. The strategy includes proactive patient outreach, community-based partnerships and vaccine clinics, and robust, education-focused marketing, all aimed at increasing COVID-19 vaccination rates. “We are committed
WOONSOCKET, R.I. — CVS Health’s fourth quarter sales and earnings easily beat Wall Street’s projections, as a rise in script counts lifted its results. Adjusted earnings per share were $1.30, bettering analysts’ forecast by 6 cents. Revenue for the period ended December 31 rose 4% from a year earlier to $69.55 billion, also topping predictions.
WOONSOCKET, R.I. — Beginning Thursday, February 11, CVS Health will start to offer COVID-19 vaccinations to eligible populations at a limited number of CVS Pharmacy locations across 11 states. Supply for the initial rollout, which is sourced directly from the federal government through the pharmacy partnership program, will be approximately 250,000 total doses. As more
WOONSOCKET, R.I. — CVS Health announced on Monday that Karen Lynch has assumed the position of president and chief executive officer at the company. In her new role, she will lead nearly 300,000 colleagues who are passionate about transforming health care to be simpler, more convenient and more personalized. As previously announced, Lynch is replacing
WOONSOCKET, R.I. — CVS Health announced it has administered the first round of COVID-19 vaccine doses to nearly 8,000 skilled nursing facilities across the country, delivering on goals established early in the process and communicated to participating states and jurisdictions months ago. Administration of second doses is well underway and expected to be complete within
WOONSOCKET, R.I. — The following is attributed to Karen S. Lynch, currently Executive Vice President, CVS Health and President, Aetna, who will become the company’s next President and CEO on February 1: “We agree with President-elect Biden that pharmacies will play a critical role in the next phase of the COVID-19 vaccine rollout and appreciate his leadership
WOONSOCKET, R.I. — CVS Health announced that president and chief executive officer Larry Merlo, executive vice president and chief financial officer Eva Boratto, and executive vice president and president, Aetna Karen Lynch, who will become the company’s next president and CEO on February 1, will participate in a fireside chat with investors at the J.P.
WOONSOCKET, R.I.— CVS Health announced on Monday that Larry Merlo, president and chief executive officer; and Eva Boratto, executive vice president and chief financial officer; and Karen Lynch, executive vice president and president of Aetna will be participating in a fireside chat with investors at the Evercore ISI 3rd Annual Global HealthCONx Conference on December
WOONSOCKET, R.I. — CVS Health announced on Wednesday that Daniel Finke has been named executive vice president, CVS Health and president, Health Care Benefits Segment (HCB) effective February 1, 2021. Finke will succeed Karen Lynch, who will become president and CEO of CVS Health in February. HCB provides solutions to employers and government businesses, serving more
WOONSOCKET, R.I. — CVS Health’s board of directors announced on Friday that Larry Merlo, who has served as CEO of CVS Health for a decade, is stepping down from his role next year and Karen Lynch, currently executive vice president, CVS Health and president, Aetna, will become the company’s next president and chief executive officer,